comparemela.com

Latest Breaking News On - Krishna kiran - Page 1 : comparemela.com

FMMCH Inaugurates Pre-eclampsia Screening Clinic on World Pre-eclampsia Day

FMMCH Inaugurates Pre-eclampsia Screening Clinic on World Pre-eclampsia Day Mangaluru: Pre-eclampsia, a complex multisystem disease is diagnosed by sudden

Krishna kiranJoylened almeidaDeepa kanagalAntony sylvand souzaDepartment of radioDr prathima prabhu department of fetal medicineDr joylene from departmentPre eclampsia screening clinicWorld pre eclampsiaWorld pre eclampsia dayRadio diagnosisFetal medicineAssistant professorAssociate professorDean dr antony sylvand souzaPost graduates

Father Muller Charitable Institutions Celebrates International Workers Day with Blessing of State-of-the-Art Radio Diagnosis Machines

Father Muller Charitable Institutions Celebrates International Workers Day with Blessing of State-of-the-Art Radio Diagnosis Machines Mangaluru:

Antony sheraKrishna kiranRichard aloysius coelhoNelson dheeraj paisHead of the department radio diagnosisInternational workers dayFather muller college hospitalRadio diagnosis departmentDepartment of radio diagnosisState of the art radio diagnosisFather muller charitable institutionsPatron saintJoseph chapelDigital radiographyDigitalx rayRadio diagnosis

3T MRI, Fetal Imaging USG and Kranium at FATHER MULLER

3T MRI, Fetal Imaging USG and Kranium at FATHER MULLER Mangaluru: The Father Muller Medical College Hospital in its drive for GEN NEXT care for its

Kishan shetty deputyPeter paul saldanhaMichael dsouzaKrishna kiranRichard aloysius coelhoMangalore diocese most revManagement committee membersFather muller medical college hospitalFetal imagingMangalore diocese mostEntrepreneur mr michaeld souzaRam shenoy bastiHigh magneticHigher resolutionAdvanced imagingDiffusion tensor imaging

Hip-Related Complications Highly Prevalent Among Youngsters Due to Excess Steroid Use

Hip-Related Complications Highly Prevalent Among Youngsters Due to Excess Steroid Use
newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.

New delhiKrishna kiranDeepak gautamAge groupExcess steroidRevision hipKnee replacement medicover groupGreen entrepreneurship awardsCircular economy

Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

Published: Dec 24, 2020 HYDERABAD, India, Dec. 24, 2020 /PRNewswire/ COVAXX s UB-612 is the first multitope, synthetic peptide-based COVID-19 vaccine candidate in clinical trials and it utilizes normal refrigeration (no freezing required) for distribution Agreement leverages Aurobindo s existing development, commercial and manufacturing infrastructure Phase 2/3 clinical trials by COVAXX to begin early 1Q 2021 in Asia, Latin America and USA Important step in ensuring equitable access and global supply during worldwide pandemic Aurobindo Pharma Limited (NSE: AUROPHARMA) (BSE: 524804) (Reuters: ARBN.NS) (Bloomberg: ARBP:IN) and COVAXX, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and the United Nations Children s Fund (UNICEF) agency. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.

New yorkUnited statesAndhra pradeshUnited kingdomSouth africaKrishna kiranAurobindo pharmaCitigate dewe rogersonUnited biomedical incAurobindo pharma limitedUnited nations children fundCompany codesHealth canadaLatin americaPharma limitedExclusive license agreement

vimarsana © 2020. All Rights Reserved.